Supplier Type
- Manufacturer
- Reagent
- Trader
- custom synthesis
- contract manufacturer
Supplier Region
- Maharashtra(37)
- Bangalore(2)
- Pune(8)
- Mumbai(72)
- Gujarat(45)
- New Delhi(8)
- Hyderabad(23)
- Ahmedabad(16)
- Karnataka(6)
- Beijing(2)
- Andhra Pradesh(2)
- Punjab(2)
- Haryana(3)
- Uttar Pradesh(4)
- Madhya Pradesh(1)
- Vadodara(12)
- Kolkata(3)
- Delhi(13)
- Tamil Nadu(2)
- Telangana(4)
- Nagpur(1)
Purity
- Zirconium Octoate 6%, 12%, 18%, 24%
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- more than 95%
- more than 90%
- Min 98%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Magnesium content Min. 12 %
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- Content of Chromium 0.2 % to 0.3 %
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- >99.95%
- 99.91%
- 99.90%
- 99.9%
- 99.86%
- 99.85%
- 99.80%
- 99.73%
- 99.55%
- 99.5%
- 99.42%
- 99.29%
- 99.00%
- 99.0%
- 99% and above
- >99%
- 99%
- 98+
- 98.90%
- 98.60%
- 98.58%
- 98.57%
- 98.12%
- 98.00%
- > 98%
- 98%
- >98%
- 97-99%
- 97.85%
- 97.80%
- 97.57%
- 97.00%
- 97%
- >97%
- 97 %
- 96-98%
- 96.80%
- 96.64%
- 96.40%
- 96.39%
- 96.14%
- 96%
- 95.48%
- 95.00%
- 95%
- >95%
- 94.00%
- >92%
- 90%
- >90%
- 90 % Above
- 3-8%, 12%
- 12%/15%
- 12%
- 10-12 %
- 100%
- 100
- 0.5M
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 1mg
- 25
- 200
- 100
- 25mg
- 50mg
- 255025kg in 50litre HDPE drum
- 50
- 0MG TO GRAM
- 11Between 1 gm to 1 MT (As per availability)
- 100mg
- 250mg
- 500mg
- 1g
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100ml
- 100g
- 500ml
- 500g
- 1kg
- 1L
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1and gm
- 1MT
- 250kgs
- 250250 mg.
-
Efinaconazole 4-Desfluoro Impurity
-
2-((R)-1-((R)-2-(2,4-difluorophenyl)oxiran-2-yl)ethoxy)tetrahydro-2H-pyran
135267-12-8
-
Efinaconazole N-Oxide Impurity 2 -
Efinaconazole Impurity 32
2055038-63-4
-
4-METHYLENEPIPERIDINE
148133-82-8
-
(2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol
133775-25-4
-
Piperidine, 1-benzoyl-4-methylene-
188904-84-9
-
N-((S)-1-(3-(3-amino-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide
2375020-20-3
-
1H-Indazole-5-propanoic acid, α-[[[4-(1,2-dihydro-2-oxo-3-quinolinyl)-1-piperidinyl]carbonyl]amino]-7-methyl-, methyl ester, (αR)-
928014-64-6
-
Sacubitril Impurity
1015037-46-3
Sec- Butyl Lithium 12% in Cyclo hexane 598-30-1
Diisononyl phthalate 28553-12-0
N,N-Dimethylformamide 68-12-2
Direct Yellow 12 2870-32-8
(22S)-22-[(1,1-dimethylethoxy)carbonyl]-10,19,24-trioxo-3,6,12,15-Tetraoxa-9,18,23-triazahentetracontanedioic acid 41-(1,1-dimethylethyl) ester 1118767-16-0
Ethyl orange 6287-12-3
Linagliptin 668270-12-0
N-Iodosuccinimide 516-12-1
Linagliptin 668270-12-0
Reactive Orange 12 (C.I 13248) 70161-14-7